January 17, 2021 05:17 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Veteran actor Biswajit Chatterjee conferred Indian Personality of Year Award at 51st IFFI | Covid-19 vaccination drive: Serum Institute of India CEO Adar Poonawalla gets inoculated | Iranian film Bandar Band wins best film at 26th KIFF | Brisbane Test: India 62/2 at stumps on day 2, trail Australia by 307 runs | Actor Sudeep to be chief guest at IFFI opening ceremony
UK to pilot revolutionary blood test potentially detecting 50 types of cancer Cancer
Image: Pixabay

UK to pilot revolutionary blood test potentially detecting 50 types of cancer

India Blooms News Service | @indiablooms | 27 Nov 2020, 06:29 pm

London/Sputnik: The United Kingdom's National Health Service (NHS) announced on Friday that trials of a revolutionary blood test developed by US company Grail to identify 50 types of cancer will begin in England in mid-2021.

"The Galleri blood test, developed by GRAIL, can detect early stage cancers through a simple blood test, and will be piloted with 165,000 patients in a world-first deal struck by NHS England," the NHS said in a statement.

According to the NHS, preliminary research found that the test, which checks for molecular changes in blood, can spot neck, ovarian, pancreatic, esophagus and other types of cancer that are difficult to diagnose in their early stages.

"If the NHS programme shows the test also works as expected for people without symptoms it will be rolled out to become routinely available," it added.

Reacting to the announcement, UK Prime Minister Boris Johnson wrote on Twitter that it was a "hugely promising breakthrough that could transform how we diagnose & treat cancer which still takes too many before their time."

Johnson also said it was "another example of UK scientific leadership" and thanked UK scientists and the NHS for making it happen.

The pilot will include 140,000 people aged 50 to 79 with no cancer symptoms and another 25,000 people with possible cancer symptoms to speed up their diagnosis, and the first results are expected by 2023.